Exploratory Metabolomics Underscores the Folate Enzyme ALDH1L1 As a Regulator of Glycine and Methylation Reactions

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2022 Dec 11

PMID 36500483

Authors

Blake R Rushing

Halle M Fogle

Jaspreet Sharma

Mikyoung You

Jonathan P McCormac

Sabrina Molina

Susan Sumner

Natalia I Krupenko

Sergey A Krupenko

Affiliations

Soon will be listed here.

Abstract

Folate (vitamin B9) is involved in one-carbon transfer reactions and plays a significant role in nucleic acid synthesis and control of cellular proliferation, among other key cellular processes. It is now recognized that the role of folates in different stages of carcinogenesis is complex, and more research is needed to understand how folate reactions become dysregulated in cancers and the metabolic consequences that occur as a result. ALDH1L1 (cytosolic 10-formyltetrahydrofolate dehydrogenase), an enzyme of folate metabolism expressed in many tissues, is ubiquitously downregulated in cancers and is not expressed in cancer cell lines. The RT4 cell line (derived from papillary bladder cancer) which expresses high levels of ALDH1L1 represents an exception, providing an opportunity to explore the metabolic consequences of the loss of this enzyme. We have downregulated this protein in RT4 cells (shRNA driven knockdown or CRISPR driven knockout) and compared metabolomes of ALDH1L1-expressing and -deficient cells to determine if metabolic changes linked to the loss of this enzyme might provide proliferative and/or survival advantages for cancer cells. In this study, cell extracts were analyzed using Ultra High Performance Liquid Chromatography High Resolution Mass Spectrometry (UHPLC-HR-MS). A total of 13,339 signals were identified or annotated using an in-house library and public databases. Supervised and unsupervised multivariate analysis revealed metabolic differences between RT4 cells and ALDH1L1-deficient clones. Glycine (8-fold decrease) and metabolites derived from S-adenosylmethionine utilizing pathways were significantly decreased in the ALDH1L1-deficient clones, compared with RT4 cells. Other changes linked to ALDH1L1 downregulation include decreased levels of amino acids, Krebs cycle intermediates, and ribose-5-phosphate, and increased nicotinic acid. While the ALDH1L1-catalyzed reaction is directly linked to glycine biosynthesis and methyl group flux, its overall effect on cellular metabolism extends beyond immediate metabolic pathways controlled by this enzyme.

Citing Articles

An untargeted metabolomic analysis of acute AFB1 treatment in liver, breast, and lung cells.

Cao H, Molina S, Sumner S, Rushing B PLoS One. 2025; 20(1):e0313159.

PMID: 39883710 PMC: 11781672. DOI: 10.1371/journal.pone.0313159.

Disrupted mitochondrial morphology and function exacerbate inflammation in elderly-onset ulcerative colitis.

Zhang M, Lv H, Bai X, Ruan G, Li Q, Lin K Immun Ageing. 2025; 22(1):4.

PMID: 39794776 PMC: 11721460. DOI: 10.1186/s12979-024-00494-5.

Untargeted Metabolomics Reveals Dysregulation of Glycine- and Serine-Coupled Metabolic Pathways in an ALDH1L1-Dependent Manner In Vivo.

Fu G, Molina S, Krupenko S, Sumner S, Rushing B Metabolites. 2024; 14(12).

PMID: 39728477 PMC: 11677661. DOI: 10.3390/metabo14120696.

Metabolomics Analysis Reveals Altered Metabolic Pathways and Response to Doxorubicin in Drug-Resistant Triple-Negative Breast Cancer Cells.

Rushing B, Molina S, Sumner S Metabolites. 2023; 13(7).

PMID: 37512572 PMC: 10383792. DOI: 10.3390/metabo13070865.

Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells.

Rushing B, Wiggs A, Molina S, Schroder M, Sumner S Int J Mol Sci. 2023; 24(5).

PMID: 36901842 PMC: 10002396. DOI: 10.3390/ijms24054406.

References

Broadhurst D, Goodacre R, Reinke S, Kuligowski J, Wilson I, Lewis M . Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018; 14(6):72. PMC: 5960010. DOI: 10.1007/s11306-018-1367-3. View

Loras A, Martinez-Bisbal M, Quintas G, Gil S, Martinez-Manez R, Ruiz-Cerda J . Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer. Cancers (Basel). 2019; 11(7). PMC: 6678457. DOI: 10.3390/cancers11070914. View

Faubert B, Solmonson A, DeBerardinis R . Metabolic reprogramming and cancer progression. Science. 2020; 368(6487). PMC: 7227780. DOI: 10.1126/science.aaw5473. View

Gao J, Tarcea V, Karnovsky A, Mirel B, Weymouth T, Beecher C . Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks. Bioinformatics. 2010; 26(7):971-3. PMC: 2844990. DOI: 10.1093/bioinformatics/btq048. View

Cooperman J, Lopez R . The role of histidine in the anemia of folate deficiency. Exp Biol Med (Maywood). 2002; 227(11):998-1000. DOI: 10.1177/153537020222701107. View

Kamat A, Hahn N, Efstathiou J, Lerner S, Malmstrom P, Choi W . Bladder cancer. Lancet. 2016; 388(10061):2796-2810. DOI: 10.1016/S0140-6736(16)30512-8. View

Pavlova N, Thompson C . The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016; 23(1):27-47. PMC: 4715268. DOI: 10.1016/j.cmet.2015.12.006. View

Conde V, Oliveira P, Nunes A, Rocha C, Ramalhosa E, Pereira J . The progression from a lower to a higher invasive stage of bladder cancer is associated with severe alterations in glucose and pyruvate metabolism. Exp Cell Res. 2015; 335(1):91-8. DOI: 10.1016/j.yexcr.2015.04.007. View

Dmitriev A, Kashuba V, Haraldson K, Senchenko V, Pavlova T, Kudryavtseva A . Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics. 2012; 7(5):502-13. DOI: 10.4161/epi.19801. View

10.

Intlekofer A, Finley L . Metabolic signatures of cancer cells and stem cells. Nat Metab. 2019; 1(2):177-188. PMC: 6594714. DOI: 10.1038/s42255-019-0032-0. View

11.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

12.

Rinne M, He Y, Pachkowski B, Nakamura J, Kelley M . N-methylpurine DNA glycosylase overexpression increases alkylation sensitivity by rapidly removing non-toxic 7-methylguanine adducts. Nucleic Acids Res. 2005; 33(9):2859-67. PMC: 1131935. DOI: 10.1093/nar/gki601. View

13.

Moore L, Malats N, Rothman N, Real F, Kogevinas M, Karami S . Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer. 2007; 120(11):2452-8. DOI: 10.1002/ijc.22565. View

14.

Oleinik N, Krupenko S . Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in A549 cells induces G1 cell cycle arrest and apoptosis. Mol Cancer Res. 2003; 1(8):577-88. View

15.

Liu H, Tan Q, Geddie W, Jewett M, Phillips N, Ke D . Biophysical characterization of bladder cancer cells with different metastatic potential. Cell Biochem Biophys. 2013; 68(2):241-6. DOI: 10.1007/s12013-013-9702-9. View

16.

Armitage E, Barbas C . Metabolomics in cancer biomarker discovery: current trends and future perspectives. J Pharm Biomed Anal. 2013; 87:1-11. DOI: 10.1016/j.jpba.2013.08.041. View

17.

Bergers G, Fendt S . The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021; 21(3):162-180. PMC: 8733955. DOI: 10.1038/s41568-020-00320-2. View

18.

Valikangas T, Suomi T, Elo L . A systematic evaluation of normalization methods in quantitative label-free proteomics. Brief Bioinform. 2016; 19(1):1-11. PMC: 5862339. DOI: 10.1093/bib/bbw095. View

19.

Hoeferlin L, Oleinik N, Krupenko N, Krupenko S . Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer. 2012; 2(9):889-99. PMC: 3352155. DOI: 10.1177/1947601911432495. View

20.

Krupenko S, Krupenko N . Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression. Chem Biol Interact. 2019; 302:149-155. PMC: 6433412. DOI: 10.1016/j.cbi.2019.02.013. View